(PREPRINT) Psychedelics and schizophrenia: Distinct alterations to Bayesian inference (Rajpal et al.)

Open access: Feb 1, 2022
bioRxiv

~

Repeated low doses of LSD in healthy adults: A placebo-controlled, dose–response study (de Wit et al.)

Published: Feb 1, 2022
Addiction Biology

~

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking (Wießner et al.)

Published: Feb 1, 2022
Journal of Psychopharmacology

~

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science (Schlag et al.)

Published: Feb 2, 2022
Journal of Psychopharmacology

~

Reduced precision underwrites ego dissolution and therapeutic outcomes under psychedelics (Stoliker et al.)

Provisionally accepted: Feb 2, 2022
Frontiers in Neuroscience

--

--

Psychedelic Science Updates (@UpdatesPsy)
Psychedelic Science Updates (@UpdatesPsy)

Written by Psychedelic Science Updates (@UpdatesPsy)

Updates on the latest peer-reviewed & preprint psychedelic research and clinical trials. Twitter handle @UpdatesPsy or @UpdatesPsy@mastodon.social on Mastodon.

No responses yet